West Pharmaceutical Services Stock News

West Pharmaceutical Services, I found using ticker (WST) now have 5 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 515 and 405 with a mean TP of 457. With the stocks previous close at 449.36 this indicates there is a potential upside of 1.7%. The 50 day MA is 426.94 and the 200 day MA is 366.14. The market capitalisation for the company is $33,221m. Company Website: /> [stock_market_widget type="chart" symbol="WST" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] West Pharmaceutical Services designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.

Symphony Financial Ltd. Co. purchased a new position in West Pharmaceutical Services, Inc. (NYSE:WST) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 880 shares of the medical instruments suppliers stock, valued at approximately $381,000. A number of other hedge funds have also []

In recent trading, shares of West Pharmaceutical Services, Inc. (Symbol: WST) have crossed above the average analyst 12-month target price of $448.75, changing hands for $449.36/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher [] The post WST Crosses Above Average Analyst Target appeared first on UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News .

Leading Players of Global Pharmaceutical Packaging Market are Gerresheimer , West Pharmaceutical Services , MeadWestvaco, WestRock , Rexam , Owens Illinois , Klockner Pentaplast Group etc. According to the new report published

West Pharmaceutical (WST) continues to gain momentum on the back of strength in Proprietary Products business.

Zacks Investment Research lowered shares of West Pharmaceutical Services (NYSE:WST) from a buy rating to a hold rating in a research report report published on Friday morning, Zacks.com reports. Zacks Investment Research currently has $438.00 price objective on the medical instruments suppliers stock. According to Zacks, West Pharmaceutical exited third-quarter 2021 on a strong note, []

Related Stocks: USMV , TMUS , POOL , WST , CMCSA , RE , IWN , MDLA , FIVN , CVA , XLRN , PFTA , WORK , ALXN , PFPT , COHR , GOLD , CENH ,

West Pharmaceutical (WST) could produce exceptional returns because of its solid growth attributes.

Comerica Bank trimmed its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 9.9% during the second quarter, HoldingsChannel.com reports. The firm owned 26,281 shares of the medical instruments suppliers stock after selling 2,890 shares during the quarter. Comerica Banks holdings in West Pharmaceutical Services were worth $11,747,000 as of its most recent filing []

EXTON, Pa., Nov. 11, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will part

West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 15 years by 12.12% on an annualized basis. Buying $1,000 In WST: 15 years ago, an investor could have purchased 40.06 sha

I present my top 15 dividend growth stocks to consider during the month of November. Last month's list returned 8.52% in October, outpacing SPY by 1.5%.

West Pharmaceutical's (WST) third-quarter earnings reflect segmental strong performance.

West Pharmaceutical (WST) delivered earnings and revenue surprises of 13.19% and 3.18%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?